Replimune Group, Inc. · NASDAQ:REPL
Xynos Konstantinos sold 11,447 Replimune Group, Inc. shares (Form 4)
Traded Aug 10, 2026 · Filed Aug 12, 2026
On Aug 10, 2026, Xynos Konstantinos (Chief Medical Officer) sold 11,447 Replimune Group, Inc. shares at US$12.97 for US$148K, leaving 224,215 shares. Filed Aug 12, 2026 (Form 4).
- Sold
- 11,447 shares
- Price
- US$12.97
- Value
- US$148K
- Holding after
- 224,215 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | Sale | 11,447 | US$12.97 | 224,215 | Direct |
Source
Related
- Replimune Group, Inc.
- Xynos Konstantinos
- Replimune Group, Inc. shareholders
- Form 4 · Xynos Konstantinos · May 20, 2026
- Form 4 · Xynos Konstantinos · Apr 7, 2026
- Form 4 · Astley-Sparke Philip · Aug 24, 2026
- Form 4 · Hill Emily Luisa · Aug 19, 2026
- Schedule 13G/A · Ridgeback Capital Investments L.P. · Aug 14, 2026
- Form 4 · Patel Sushil · Aug 12, 2026
- Form 4 · Hill Emily Luisa · Aug 12, 2026